Cargando…

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection

PURPOSE: Cefathiamidine, a first-generation cephalosporin, has approval from the China Food and Drug Administration for the treatment of infections caused by susceptible bacteria in both adults and children. As pharmacokinetic data are limited in the pediatric population, we aimed to evaluate the po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhi, Li-Juan, Wang, Li, Chen, Xing-Kai, Zhai, Xiao-Ying, Wen, Li, Dong, Lei, Jacqz-Aigrain, Evelyne, Shi, Zhong-Ren, Zhao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909787/ https://www.ncbi.nlm.nih.gov/pubmed/29713143 http://dx.doi.org/10.2147/DDDT.S160329

Ejemplares similares

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
por: Du, Bin, et al.
Publicado: (2021)

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
por: Aurich, Beate, et al.
Publicado: (2021)

Penicillin acylase-catalyzed synthesis of N-bromoacetyl-7-aminocephalosporanic acid, the key intermediate for the production of cefathiamidine
por: Zhang, Xiao-Li, et al.
Publicado: (2016)

Ciprofloxacin safety in paediatrics: a systematic review
por: Adefurin, Abiodun, et al.
Publicado: (2011)

Clinical trials in neonates: How to optimise informed consent and decision making? A European Delphi survey of parent representatives and clinicians
por: Neyro, Virginia, et al.
Publicado: (2018)

Analysis of Paediatric Clinical Trial Characteristics and Activity Over 23 Years—Impact of the European Paediatric Regulation on a Single French Clinical Research Center
por: Arnadottir, Johanna, et al.
Publicado: (2022)

Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach
por: Kaguelidou, Florentia, et al.
Publicado: (2016)

Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis
por: D’Agate, S., et al.
Publicado: (2021)

Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry
por: Desselas, Emilie, et al.
Publicado: (2017)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
por: Li, Qian, et al.
Publicado: (2019)

European survey on the use of prophylactic fluconazole in neonatal intensive care units
por: Kaguelidou, Florentia, et al.
Publicado: (2011)

Safety of fluconazole in paediatrics: a systematic review
por: Egunsola, Oluwaseun, et al.
Publicado: (2013)

Use and safety of azithromycin in neonates: a systematic review
por: Smith, Coral, et al.
Publicado: (2015)

A Delphi Process to Optimize Quality and Performance of Drug Evaluation in Neonates
por: Legrand, Frederic, et al.
Publicado: (2014)

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
por: Hill, Louise F., et al.
Publicado: (2020)

Population Pharmacokinetic Analysis and Dosing Optimization of Prophylactic Fluconazole in Japanese Patients with Hematological Malignancy
por: Sakamoto, Yasutaka, et al.
Publicado: (2021)

Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey
por: Pansieri, Claudia, et al.
Publicado: (2014)

Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder
por: Konofal, Eric, et al.
Publicado: (2014)

Informed consent for neonatal trials: practical points to consider and a check list
por: Aurich, Beate, et al.
Publicado: (2020)

Wide intra- and inter-country variability in drug use and dosage in very-low-birth-weight newborns with severe infections
por: Pandolfini, Chiara, et al.
Publicado: (2012)

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies
por: Laille, Eric, et al.
Publicado: (2015)

Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients
por: Vignal, Nicolas, et al.
Publicado: (2023)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis
por: Adam de Beaumais, Tiphaine, et al.
Publicado: (2022)

Pharmacokinetics and Optimal Dosing of Phenobarbital
por: Shareef, Safiullah, et al.
Publicado: (2018)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
por: Niu, Chang-He, et al.
Publicado: (2020)

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?
por: Durrmeyer, Xavier, et al.
Publicado: (2010)

Dose Schedule Optimization and the Pharmacokinetic Driver of Neutropenia
por: Patel, Mayankbhai, et al.
Publicado: (2014)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
por: Fu, Wen-Qian, et al.
Publicado: (2022)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

A New Model to Describe the Single-dose Pharmacokinetics of Bevacizumab and Predict Its Multiple-Dose Pharmacokinetics in Beagle Dogs
por: Li, Meizhen, et al.
Publicado: (2019)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
por: Wang, Yang, et al.
Publicado: (2022)

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
por: Li, SiChan, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
por: White, Nicholas J.
Publicado: (2013)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Paediatric clinical research in Europe: an insight on experts’ needs and perspectives
por: Ruggieri, Lucia, et al.
Publicado: (2021)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
por: Zhao, Sixuan, et al.
Publicado: (2021)

Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation
por: Chen, Xiao, et al.
Publicado: (2022)

Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases
por: Khan-asa, Buddharat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5nta074nfe13n8kq27trlvsl3p